The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective study to assess taste related to eating disorders during chemotherapy using a dietary app: OISHY study.
 
Toshiharu Hirose
No Relationships to Disclose
 
HIroko Abe
No Relationships to Disclose
 
Hayato Tsuchiya
No Relationships to Disclose
 
Honoka Funaki
Employment - Oishi Kenko, Inc.
 
Kazuki Hamada
Employment - Oishi Kenko, Inc.
Stock and Other Ownership Interests - Oishi Kenko, Inc.
 
Tetsuya Nojiri
Employment - Oishi Kenko, Inc.
Leadership - Oishi Kenko, Inc.
Stock and Other Ownership Interests - Oishi Kenko, Inc.
 
Ken Kato
Honoraria - BMS; Lilly; Ono Pharmaceutical
Consulting or Advisory Role - Bayer; BeiGene; MSD; Oncolys BioPharma; Ono Pharmaceutical
Speakers' Bureau - Bristol-Myers Squibb Japan; MSD; Ono Pharmaceutical
Research Funding - AstraZeneca (Inst); Bayer (Inst); Beigene (Inst); Chugai Pharma (Inst); MSD Oncology (Inst); Ono Pharmaceutical (Inst); Shionogi (Inst); Taiho Pharmaceutical (Inst)